2‐Nitroveratryl as a Photocleavable Thiol‐Protecting Group for Directed Disulfide Bond Formation in the Chemical Synthesis of Insulin
John A. Karas(Biotechnology Institute), Mohammed Akhter Hossain(The University of Melbourne), John D. Wade(The University of Melbourne), Richard J. Lewis(AstraZeneca (Netherlands)), Briony E. Forbes(Flinders University), James Gardiner(Division of Materials Science and Engineering), Irina Vetter(Centre National de la Recherche Scientifique), Frances Separovic(The University of Melbourne), Denis B. Scanlon(Biotechnology Institute)
Cited by 67
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422